Copa Holdings (CPA) closed the last trading session at $106.47, gaining 17.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $152.73 indicates a 43.5% upside potential.The average comprises 11 short-term price targets ranging from a low of $125 to a high of $190, with a standard deviation of $19.78. While the lowest estimate indicates an increase of 17.4% from the current price le ...

Priority Technology (PRTH) closed the last trading session at $7.66, gaining 4.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.80 indicates a 67.1% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $2.77. While the lowest estimate of $10 indicates a 30.6% increase from the current price level, the most optimistic analyst ...

Braze, Inc. (BRZE) closed the last trading session at $34.73, gaining 11.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $50.16 indicates a 44.4% upside potential.The mean estimate comprises 19 short-term price targets with a standard deviation of $9.15. While the lowest estimate of $38 indicates a 9.4% increase from the current price level, the most optimistic analyst expects t ...

Kontoor Brands (KTB) closed the last trading session at $69.62, gaining 13.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $87.83 indicates a 26.2% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $9.22. While the lowest estimate of $72 indicates a 3.4% increase from the current price level, the most optimistic analyst expect ...

Group 1 - Immunome, Inc. (IMNM) shares have increased by 1.1% over the past four weeks, closing at $8.49, with a mean price target of $24.50 indicating a potential upside of 188.6% [1] - The mean estimate consists of eight short-term price targets with a standard deviation of $5.76, where the lowest estimate of $20 suggests a 135.6% increase, and the highest estimate predicts a surge of 347.6% to $38 [2] - Analysts show a consensus that IMNM will report better earnings than previously estimated, which strengthens the outlook for the stock [4][11] Group 2 - Over the last 30 days, five earnings estimates for IMNM have been revised upward, resulting in a Zacks Consensus Estimate increase of 17.9% [12] - IMNM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - The correlation between earnings estimate revisions and near-term stock price movements suggests that the positive trend in earnings estimates could lead to stock price increases [11]

Core Viewpoint - Si-Bone (SIBN) shares have increased by 27.6% in the past four weeks, closing at $18.38, with a mean price target of $24.67 indicating a potential upside of 34.2% [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $3.57, where the lowest estimate is $19 (3.4% increase) and the highest is $32 (74.1% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts are optimistic about SIBN's earnings prospects, as indicated by a positive trend in earnings estimate revisions, with five estimates moving higher and no negative revisions in the last 30 days, resulting in a 7.7% increase in the Zacks Consensus Estimate [11][12] - SIBN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Pediatrix Medical Group (MD) closed the last trading session at $13.56, gaining 10.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $17.14 indicates a 26.4% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $2.61. While the lowest estimate of $14 indicates a 3.2% increase from the current price level, the most optimistic anal ...

Core Viewpoint - P3 Health Partners Inc. (PIII) is experiencing significant selling pressure, having declined 18.4% over the past four weeks, but is now positioned for a potential trend reversal as it is in oversold territory and analysts expect better earnings than previously predicted [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key indicator used to determine if a stock is oversold, with a reading below 30 typically indicating this condition [2]. - PIII's current RSI reading is 23.11, suggesting that the heavy selling pressure may be exhausting itself, indicating a potential trend reversal [5]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts that earnings estimates for PIII have increased by 7.8% over the last 30 days, which often correlates with price appreciation [7]. - PIII holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [8].

Nerdy Inc. (NRDY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual investo ...

Core Viewpoint - The stock price of Stem, Inc. (STEM) has recently experienced a bearish trend, losing 16% over the past week, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be emerging [1][2]. Group 1: Technical Analysis - The hammer chart pattern indicates a potential bottom in the stock price, suggesting that selling pressure may be exhausting [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, indicating that despite a downtrend, buying interest has emerged to push the stock price up towards the opening price [4][5]. - The occurrence of a hammer pattern at the bottom of a downtrend signals that bears may have lost control, indicating a possible trend reversal [5]. Group 2: Fundamental Analysis - Recent upward revisions in earnings estimates for STEM are viewed as a bullish indicator, correlating strongly with near-term stock price movements [7]. - The consensus EPS estimate for the current year has increased by 23.9% over the last 30 days, reflecting analysts' optimism about the company's earnings potential [8]. - STEM holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9].